Jupiter Life Line Hospitals Limited has informed the Exchange regarding Appointment & Change in Designation of Dr. Ajay Thakker as Chairman & Whole Time Director of the company w.e.f. July 17, 2026.
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jupiter Life Line Hospitals reported audited consolidated revenue of Rs. 15,421.55 million for FY2025-26, up 15.9% from Rs. 13,307.49 million in FY2024-25. Net profit increased to Rs. 1,941.87 million from Rs. 1,937.54 million. The company announced a 10% interim dividend (Rs. 1 per share) with record date May 22, 2026. Key governance changes include a 1:5 stock split (Rs. 10 face value to Rs. 2) and appointment of Dr. Ajay Thakker as Chairman & Whole Time Director effective July 17, 2026. Two senior managerial personnel (Aditya Gupta and Dr. Tushar Patil) were also appointed. New internal and cost auditors were appointed for FY2026-27. Total assets grew to Rs. 23,831.29 million from Rs. 19,357.50 million.
The stock split will increase share affordability and liquidity for retail investors. Strong revenue growth with stable profitability reflects operational expansion. The leadership elevation of Dr. Ajay Thakker reinforces continuity in the Thakker family's management control of the hospital group.